USPTO serial 78181702
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
New York, NY
New York, NY
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Stacey Hallerman
STACEY HALLERMAN C/O PRIZER INC150 E 42ND STNEW YORK, NY 10017UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, viral disorders, fungal disorders; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, dermatological preparations, gynecological preparations, osteoporosis preparations, opthalmological preparations | ABANDONED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 1, 2005 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Jul 1, 2005 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Jun 1, 2005 | DOCK | ASSIGNED TO EXAMINER | — |
| May 31, 2005 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 21, 2005 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 8, 2005 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 7, 2005 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 15, 2005 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Feb 7, 2005 | PAPER RECEIVED | — | |
| Jan 31, 2005 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jan 31, 2005 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 16, 2004 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jul 16, 2004 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jul 16, 2004 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 19, 2004 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Feb 3, 2004 | EXT1 | SOU EXTENSION 1 FILED | — |
| Feb 3, 2004 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 19, 2003 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 27, 2003 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 7, 2003 | NPUB | NOTICE OF PUBLICATION | — |
| Apr 8, 2003 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 27, 2003 | DOCK | ASSIGNED TO EXAMINER | — |